Contents of this document
- Establishment of the Food, Pharmaceuticals and Cosmetics segment
- Decision to construct Okagaki Lab, a land-based aquaculture facility
- Capital and business alliance with LiLz concerning remote solutions using IoT and AI
- Year-on-year change in sales of proprietary products19.3 %
- Record-high net sales¥13,597 million
- Record-high operating profit¥874 million
- Number of segments with year-on-year net sales growth7 Segment
- Number of segments with year-on-year growth in segment profit8 Segment
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥13,597 million (YoY +10.2%) |
| Operating profit | ¥874 million (YoY +36.9%) |
| Ordinary income | ¥976 million (YoY +33.7%) |
| Net income | ¥636 million (profit attributable to owners of the parent) (YoY +26.6%) |
| Gross Profit Margin | Approximately 27.3% (gross profit of ¥3,716 million / net sales of ¥13,597 million) |
| Operating profit margin | 6.4 % |
| Selling, general and administrative expenses | ¥2,841 million |
| Results for the three months of the current quarter | Net Sales ¥13,597 million / Gross profit ¥3,716 million / Selling, general and administrative expenses ¥2,841 million / Operating profit ¥874 million / Ordinary income ¥976 million / Profit attributable to owners of parent for the quarter ¥636 million |
| Full-year earnings forecast | Net Sales ¥58,000 million / Gross profit ¥15,540 million / Selling, general and administrative expenses ¥11,320 million / Operating profit ¥4,220 million / Ordinary income ¥4,360 million / Profit attributable to owners of the parent ¥3,000 million |
| Progress against full-year forecast | Net Sales 23.4 / Gross profit 23.9 / Selling, general and administrative expenses 25 / Operating profit 20.7 / Ordinary income 22.3 / Profit attributable to owners of parent for the quarter 21.2 |
| Self-assessment against the plan | As of Q1, performance was progressing as expected toward achieving the full-year forecast. |
| Segment results | Iron and Steel Net Sales ¥3,924 million (YoY +2.0%) / Profit ¥498 million (YoY +7.1%) / Automobiles Net Sales ¥2,396 million (YoY +8.9%) / Profit ¥276 million (YoY +95.7%) / Electronics and Semiconductors Net Sales ¥2,178 million (YoY +27.1%) / Profit ¥322 million (YoY +82.3%) / Rubber and Tires Net Sales ¥777 million (YoY -27.6%) / Profit ¥101 million (YoY -11.9%) / Machine tools Net Sales ¥755 million (YoY +33.1%) / Profit ¥253 million (YoY +109.9%) / High-Performance Materials Net Sales ¥556 million (YoY +25.4%) / Profit ¥74 million (YoY +25.9%) / Environment Net Sales ¥703 million (YoY +44.6%) / Profit ¥80 million (YoY +152.6%) / Paper and Pulp Net Sales ¥233 million (YoY -3.6%) / Profit ¥28 million (YoY +11.5%) / Food, pharmaceuticals and cosmetics Net Sales ¥355 million (YoY +15.0%) / Profit ¥37 million (YoY +96.3%) / Other Net Sales ¥1,716 million (YoY +17.9%) / Profit ¥214 million (YoY -13.8%) |
| Breakdown of Factors Affecting the Change | Increase in operating profit Change in net sales Iron and Steel 76 / Automobiles 195 / Electronics and Semiconductors 464 / Rubber and Tires -297 / Machine tools 188 / High-Performance Materials 112 / Environment 216 / Paper and Pulp -8 / Food, pharmaceuticals and cosmetics 46 / Other industries 261 / Cost of sales -708 / Personnel Expenses -158 / Other SG&A expenses -153 |
| Key KPIs | Indicator name Year-on-year change in sales of proprietary products / Value 19.3 % / Year on year against the same period last year Not disclosed, Indicator name Record-high net sales / Value ¥13,597 million / Year on year against the same period last year Not disclosed, Indicator name Record-high operating profit / Value ¥874 million / Year on year against the same period last year Not disclosed, Indicator name Number of segments with year-on-year net sales growth / Value 7 Segment / Year on year against the same period last year Not disclosed, Indicator name Number of segments with year-on-year growth in segment profit / Value 8 Segment / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | Concerns over inflation caused by worsening conditions in the Middle East Already reflected in selling, general and administrative expenses (variable costs). Not reflected in net sales at this time. |
| Medium-term management plan targets | Food, Pharmaceuticals and Cosmetics segment Net sales of ¥2.3 billion in FY2030, a 40% increase from the current level / Land-based aquaculture equipment Equipment sales of ¥2.0 billion in FY2030 |
| New initiatives | Establishment of the Food, Pharmaceuticals and Cosmetics segment, Decision to construct Okagaki Lab, a land-based aquaculture facility, Capital and business alliance with LiLz concerning remote solutions using IoT and AI |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales of proprietary products increased as the company captured demand from the buoyant electronics and semiconductor industries and the machine tool industry. The increase in proprietary product sales drove a substantial increase in gross profit, which more than offset the rise in selling, general and administrative expenses and resulted in higher operating profit. The change from a foreign exchange loss of approximately ¥25 million in the same quarter of the previous year to a foreign exchange gain of approximately ¥14 million in the current quarter was also cited as a factor behind the increase in ordinary profit.